Tenofovir alafenamide/elvitegravir
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tenofovir alafenamide/elvitegravir, covering 2023-12-22 to 2023-12-22. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Pharmacokinetic Study of Tenofovir Alafenamide (TAF)/Elvitegravir (EVG) Administered Rectally [Phase 1]